1. Drug safety: preliminary findings indicate persistent challenges with FDA foreign inspections : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives Publication: Washington, DC : United States Government Accountability Office, December 10, 2019 Subject(s): Drug Industry -- legislation & jurisprudenceGovernment RegulationPharmaceutical Preparations -- standardsUnited StatesUnited States. Food and Drug Administration